VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 40 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 40 | -43.7% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 71 | -42.3% | 0.00% | – |
| Q1 2022 | $1,000 | -90.9% | 123 | -82.5% | 0.00% | – |
| Q4 2021 | $11,000 | +266.7% | 704 | +252.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 200 | -60.0% | 0.00% | – |
| Q4 2020 | $6,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $4,000 | -33.3% | 500 | -10.6% | 0.00% | – |
| Q2 2020 | $6,000 | -14.3% | 559 | -16.3% | 0.00% | – |
| Q1 2020 | $7,000 | -36.4% | 668 | 0.0% | 0.00% | – |
| Q4 2019 | $11,000 | +57.1% | 668 | +24.9% | 0.00% | – |
| Q3 2019 | $7,000 | -12.5% | 535 | -6.1% | 0.00% | – |
| Q2 2019 | $8,000 | -52.9% | 570 | -39.4% | 0.00% | – |
| Q1 2019 | $17,000 | – | 940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,134,846 | $42,837,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 4,568,000 | $47,324,000 | 2.93% |
| Sio Capital Management, LLC | 721,193 | $7,472,000 | 2.50% |
| Profit Investment Management, LLC | 105,234 | $1,090,000 | 1.02% |
| Birchview Capital, LP | 80,000 | $829,000 | 0.74% |
| Teza Capital Management LLC | 15,744 | $163,000 | 0.52% |
| Leap Investments LP | 33,712 | $349,000 | 0.51% |
| GLOBEFLEX CAPITAL L P | 145,426 | $1,507,000 | 0.46% |
| TANG CAPITAL MANAGEMENT LLC | 299,800 | $3,106,000 | 0.44% |
| BOOTHBAY FUND MANAGEMENT, LLC | 278,100 | $2,881,000 | 0.24% |